FUSO CHEMICAL CO.,LTD. FY03/2024 2nd Quarter Financial Results
Period from April 1,2023 to
September 30,2023
November 14, 2023
Prime market（4368）
Tokyo Stock Exchange, Inc.
Copyright©2023 Fuso Chemical Co.,Ltd. All Rights Reserved.
Table of Contents
- Financial Summary Results for 2nd Quarter (period April 1, 2023 - September 30, 2023)
-
Segments Results ■Life Science
■Electronic Materials & Functional Chemicals
III.FY03/2024 Outlook
(period April 1, 2023 - March 31, 2024)
Copyright©2023 Fuso Chemical Co.,Ltd. All Rights Reserved. | 2 |
I. FY03/2024 1H Financial Summary
(period April 1, 2023 - September 30, 2023)
Copyright©2023 Fuso Chemical Co.,Ltd. All Rights Reserved. | 3 |
Consolidated Financial Results for FY03/2024 1H
FY03/2024 | |
（unit：100 millions of yen） | 1H |
vs FY03/2023 | Budget disclosed in May 2023 | Budget disclosed in Sep.2023 | ||||||
FY03/2023 | YoY | YoY ratio | Budget | Change vs budget | Budget | Change vs budget | ||
1H | ||||||||
Net sales | 271.3 | 353.5 | △82.2 | △23.3% ↘ | 336.0 | △64.6 | △19.2% | 274.0 | △2.6 | △1.0% |
Operating profit | 55.8 | 95.7 | △39.9 | △41.7% ↘ | 71.0 | △15.1 | △21.4% | 55.0 | ＋0.8 | ＋1.5% |
Ordinary profit | 62.4 | 107.5 | △45.1 | △41.9% ↘ | 71.0 | △8.5 | △12.0% | 60.5 | ＋1.9 | ＋3.2% |
Profit attributable to | 42.8 | 75.1 | △32.2 | △43.0% ↘ | 48.5 | △5.6 | △11.6% | 41.0 | ＋1.8 | ＋4.6% |
owners of parent | ||||||||||
EBITDA | 83.6 | 116.2 | △32.5 | △28.0% ↘ | 101.5 | △17.8 | △17.6% | 82.5 | ＋1.1 | ＋1.4% |
Earnings per | ¥121.6 | ¥213.2 | ¥△91.6 | △43.0% ↘ | ¥137.6 | ¥△15.9 | △11.6% | ¥116.3 | ¥5.3 | ＋4.6% |
share | ||||||||||
Copyright©2023 Fuso Chemical Co.,Ltd. All Rights Reserved. | 4 |
Sales & Profit by segment
versus previous year FY03/2023 1H
vs FY03/2023 1H | ||||||
(unit:100 millions of yen) | 3/'24 1H | 3/'23 1H | change | Ratio | ||
▬Life Science | Net sales | 169.7 | 193.7 | △23.9 | △12.4% ↘ | |
32.7 | ||||||
Operating profit | 33.4 | △0.7 | △2.1% ↘ | |||
▬Electronic Materials & | Net sales | 101.5 | 159.8 | △58.2 | △36.4% ↘ | |
Functional Chemicals | Operating profit | 33.3 | 71.4 | △38.1 | △53.4% ↘ | |
(Adjustment) | △10.2 | △9.1 | △1.0 | ― | ||
Operating pfofit (consolidated) | 55.8 | 95.7 | △39.9 | △41.7% ↘ | ||
Copyright©2023 Fuso Chemical Co.,Ltd. All Rights Reserved. | 5 |
FY03/2024 Quarterly Results
3/'24 | YonY | 3/'24 | YonY | |||
（unit：100 ｍillions of yen） | １Q | change | ratio | ２Q | change | ratio |
Net sales | 136.4 | △39.0 | △22.2% | 134.9 | △43.2 | △24.3% |
Operating profit | 31.9 | △14.9 | △31.9% | 23.8 | △24.9 | △51.1% |
Ordinary profit | 37.2 | △16.3 | △30.5% | 25.1 | △28.7 | △53.3% |
Profit attributable | 24.5 | △12.0 | △33.0% | 18.3 | △20.2 | △52.4% |
to owners of parent | ||||||
EBITDA | 41.8 | △14.9 | △26.4% | 41.8 | △17.5 | △29.6% |
Earnings per | ¥69.6 | ¥△34.2 | ¥52.0 | ¥△57.3 | ||
share | ||||||
Copyright©2023 Fuso Chemical Co.,Ltd. All Rights Reserved. | 6 |
FY03/2024 Quarterly Results Trends
（100 millions of | ||||
700 | yen） | |||
４Q | ||||
600 | ３Q | |||
２Q | ||||
500 | １Q | |||
413 | 422 | |||
400 | ||||
100 | 110 | |||
300 | ||||
109 | 108 |
Net Sales
557
161
144
684
605
158
172
178
（100 millions of | Operating Profit | ||||||
200 | yen） | 189 | |||||
４Q | |||||||
180 | |||||||
３Q | 42 | ||||||
160 | ２Q | 150 | |||||
１Q | |||||||
140 | |||||||
120 | 47 | 51 | 109 | ||||
100 | 88 | 96 | |||||
80 | 18 | 24 | 38 | ||||
48 | |||||||
200 | 123 | |
103 | 101 | |
100 | ||
99 | 102 | 128 |
134
175 136
60 | 25 | 25 | ||
30 | ||||
40 | 23 | |||
22 | 22 | |||
20 | 33 | 46 | ||
21 | 23 | 31 | ||
0
3/'20 | 3/'21 | 3/'22 | 3/'23 | 3/'24 |
0 | ||||
3/'20 | 3/'21 | 3/'22 | 3/'23 | 3/'24 |
Copyright©2023 Fuso Chemical Co.,Ltd. All Rights Reserved. | 7 |
Net Sales by Segment
400 （100 millions of yen）
350 | Electronic Materials & | |
300 | Functional Chemicals | |||||||||
Life Science | ||||||||||
159 | ||||||||||
250 | 146 | |||||||||
136 | ||||||||||
101 | ||||||||||
200 | 107 | |||||||||
150 | 80 | 91 | 90 | 97 | ||||||
100 | 144 | 169 | 193 | 184 | 169 | |||||
123 | 120 | |||||||||
50 | 117 | 113 | ||||||||
0 | ||||||||||
1H | 2H | 1H | 2H | 1H | 2H | 1H | 2H | 1H | 2H plan | |
3/'20 | 3/'21 | 3/'22 | 3/'23 | 3/'24 |
Copyright©2023 Fuso Chemical Co.,Ltd. All Rights Reserved. | 8 |
Operating Profit by Segment
110 (100 millions of yen) Electronic Materials & Functional Chemicals
Life Science
90 | (Adjustment) | Electronic Materials | |
profit ratio | |||
Life Science profit ratio |
70 | 71 | 62 | ||||||||
65 | ||||||||||
50 | 50 | 33 | ||||||||
30 | 26 | 31 | 35 | 40 | ||||||
28 | 33 | 40 | 32 | |||||||
10 | 23 | 19 | 20 | |||||||
17 | 15 | |||||||||
△ 10 | -6 | -6 | -6 | -6 | -6 | -8 | -9 | -9 | -10 | |
1H | 2H | 1H | 2H | 1H | 2H | 1H | 2H | 1H | 2H plan |
3/'20 | 3/'21 | 3/'22 | 3/'23 | 3/'24 |
60%
50%
40%
30%
20%
10%
0%
Copyright©2023 Fuso Chemical Co.,Ltd. All Rights Reserved. | 9 |
Net Profit Analysis FY03/2022 versus FY03/2023
increase
decrease
（unit:100 millions of yen）
selling, general | ||||||||
3/'23 | net sales | CGS | CGS | and | non‐operating | extraordinary | income taxes | 3/'24 |
net profit | (other) | (depreciation) administrative | profit or loss | profit or loss | net profit |
expenses
Copyright©2023 Fuso Chemical Co.,Ltd. All Rights Reserved. | 10 |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Fuso Chemical Co. Ltd. published this content on 14 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 November 2023 06:49:08 UTC.
